Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities

    loading  Checking for direct PDF access through Ovid


Renal toxicity in a 73-year-old male, using tenofovir/emtricitabine as preexposure prophylaxis, is described. Reduced renal reserve, a higher exposure to comedications and comorbidities can present a challenge when assessing the risks and benefits of tenofovir-based preexposure prophylaxis in the ageing population.

Related Topics

    loading  Loading Related Articles